Loading...

Home
ETF
VIR

VIR

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

VIR News

Oncolytics Biotech Strengthens Leadership Amid Oncology Market Surge

Jan 27 2026Newsfilter

Oncolytics Biotech Strengthens Leadership for Oncology Trials

Jan 27 2026PRnewswire

Norgine Expands Hepatology and Specialty Offerings with Exclusive Licensing Deal with Vir Biotechnology

Dec 17 2025Yahoo Finance

Vir Biotechnology Partners with Norgine, Secures €55 Million Initial Payment

Dec 16 2025Newsfilter

Vir Biotechnology Reveals Phase 2 Data at AASLD The Liver Meeting® and in NEJM, Showing High Undetectable HDV RNA Rates and Positive Safety Profile for Tobevibart and Elebsiran Combination

Nov 09 2025Newsfilter

Vir Biotechnology Reveals Phase 2 Data at AASLD The Liver Meeting® and in NEJM, Showcasing High Undetectable HDV RNA Rates and Positive Safety Profile for Tobevibart & Elebsiran Combination

Nov 09 2025Yahoo Finance

Vir Biotechnology to Take Part in the Jefferies 2025 London Healthcare Conference

Nov 07 2025Newsfilter

Top Analysts Recommend 3 Best Stocks to Purchase Now, 11/6/2025

Nov 06 2025TipRanks

GSK Exceeds Q3 Earnings and Sales Projections, Shares Rise on Increased 2025 Outlook

Oct 29 2025NASDAQ.COM

JMEE's Core Assets May Indicate 11% Growth Opportunity

Sep 22 2025NASDAQ.COM

HC Wainwright & Co. Affirms Buy Rating for Vir Biotechnology, Keeps $15 Price Target Intact

Sep 15 2025Benzinga

Midday Stock Highlights: Notable Movements from Alphabet, Bruker, Sprinklr, Dollar Tree, and Others

Sep 03 2025CNBC

Premarket Stock Highlights: Alphabet, Macy's, Dollar Tree, Six Flags, and Others Making Significant Moves

Sep 03 2025CNBC

Astera Labs Analyst Starts Coverage Optimistically; Check Out the Top 3 Initiations for Friday

Aug 29 2025Benzinga

Southwest Gas Analyst Becomes Optimistic; Check Out the Top 2 Upgrades for Friday

Aug 29 2025Benzinga

Tech Analyst Kicks Off Coverage with Optimism; Check Out Thursday's Top 5 Initiations

Aug 28 2025Benzinga